Terms: = Skin cancer AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1 AND Treatment
58 results:
1. A comprehensive overview of psoriatic research over the past 20 years: machine learning-based bibliometric analysis.
Yu C; Huang Y; Yan W; Jiang X
Front Immunol; 2023; 14():1272080. PubMed ID: 37954610
[TBL] [Abstract] [Full Text] [Related]
2. Analysis of Quinolinequinone Analogs with Promising Cytotoxic Activity against Breast cancer.
Yilmaz Goler AM; Tarbin Jannuzzi A; Biswas A; Mondal S; Basavanakatti VN; Jayaprakash Venkatesan R; Yıldırım H; Yıldız M; Çelik Onar H; Bayrak N; Jayaprakash V; TuYuN AF
Chem Biodivers; 2023 Sep; 20(9):e202300848. PubMed ID: 37590495
[TBL] [Abstract] [Full Text] [Related]
3. Chrysin-Induced Regression of Angiogenesis via an Induction of DNA Damage Response and Oxidative Stress in In Vitro and In Vivo Models of Melanoma.
Sassi A; Fredon M; Cotte AK; Fuselier C; Schneider C; Martiny L; Monchaud D; Chekir-Ghedira L; Aires V; Delmas D
Cells; 2023 Jun; 12(12):. PubMed ID: 37371032
[TBL] [Abstract] [Full Text] [Related]
4. A drug safety evaluation of pemigatinib for advanced cholangiocarcinoma.
Uson PLS; Bearss J; Babiker HM; Borad M
Expert Opin Drug Saf; 2023; 22(8):637-641. PubMed ID: 37363820
[TBL] [Abstract] [Full Text] [Related]
5. Endoscopic hemithyroidectomy plus prophylactic central neck dissection via breast approach versus gasless transaxillary approach in treating low-risk papillary thyroid cancer: a retrospective series.
Zhang X; Hu XJ; Hua KJ
Updates Surg; 2023 Apr; 75(3):707-715. PubMed ID: 36848003
[TBL] [Abstract] [Full Text] [Related]
6. Factors affecting eye conservation and metastasis in posterior uveal melanomas.
Nalcı Baytaroğlu H; Gündüz AK; Mirzayev I; Özalp Ateş FS
Eur J Ophthalmol; 2023 Sep; 33(5):2024-2033. PubMed ID: 36762394
[TBL] [Abstract] [Full Text] [Related]
7. Nano-scaled emulsion and nanogel containing Mentha pulegium essential oil: cytotoxicity on human melanoma cells and effects on apoptosis regulator genes.
Azadi S; Osanloo M; Zarenezhad E; Farjam M; Jalali A; Ghanbariasad A
BMC Complement Med Ther; 2023 Jan; 23(1):6. PubMed ID: 36624422
[TBL] [Abstract] [Full Text] [Related]
8. Tumor-specific radiosensitizing effect of the ATM inhibitor AZD0156 in melanoma cells with low toxicity to healthy fibroblasts.
Scheper J; Hildebrand LS; Faulhaber EM; Deloch L; Gaipl US; Symank J; Fietkau R; Distel LV; Hecht M; Jost T
Strahlenther Onkol; 2023 Dec; 199(12):1128-1139. PubMed ID: 36229655
[TBL] [Abstract] [Full Text] [Related]
9. Local recurrence risk in head and neck basal cell carcinoma.
Szewczyk M; Pazdrowski J; Pabiszczak M; Więckowska B; Dańczak-Pazdrowska A; Golusiński W
Otolaryngol Pol; 2022 Jun; 76(4):1-5. PubMed ID: 36047328
[TBL] [Abstract] [Full Text] [Related]
10. Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study.
Dimitriou F; Namikawa K; Reijers ILM; Buchbinder EI; Soon JA; Zaremba A; Teterycz P; Mooradian MJ; Armstrong E; Nakamura Y; Vitale MG; Tran LE; Bai X; Allayous C; Provent-Roy S; Indini A; Bhave P; Farid M; Kähler KC; Mehmi I; Atkinson V; Klein O; Stonesifer CJ; Zaman F; Haydon A; Carvajal RD; Hamid O; Dummer R; Hauschild A; Carlino MS; Mandala M; Robert C; Lebbe C; Guo J; Johnson DB; Ascierto PA; Shoushtari AN; Sullivan RJ; Cybulska-Stopa B; Rutkowski P; Zimmer L; Sandhu S; Blank CU; Lo SN; Menzies AM; Long GV
Ann Oncol; 2022 Sep; 33(9):968-980. PubMed ID: 35716907
[TBL] [Abstract] [Full Text] [Related]
11. Novel Therapeutic Approaches with DNA Damage Response Inhibitors for Melanoma treatment.
Maresca L; Stecca B; Carrassa L
Cells; 2022 Apr; 11(9):. PubMed ID: 35563772
[TBL] [Abstract] [Full Text] [Related]
12. Impact of the COVID Pandemic on Mohs Micrographic Surgery: A Nationwide Survey.
Seger E; Neill B; Hocker T; Ibrahimi O
J Drugs Dermatol; 2022 May; 21(5):545-547. PubMed ID: 35533028
[TBL] [Abstract] [Full Text] [Related]
13. Point prevalence of non-melanoma and melanoma skin cancers in Australian surfers and swimmers in Southeast Queensland and Northern New South Wales.
Climstein M; Doyle B; Stapelberg M; Rosic N; Hertess I; Furness J; Simas V; Walsh J
PeerJ; 2022; 10():e13243. PubMed ID: 35505675
[TBL] [Abstract] [Full Text] [Related]
14. Characterization and
Nair RS; Billa N; Mooi LY; Morris AP
Pharm Dev Technol; 2022 Jan; 27(1):72-82. PubMed ID: 34957920
[TBL] [Abstract] [Full Text] [Related]
15. Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy.
Kim R; Kwon M; An M; Kim ST; Smith SA; Loembé AB; Mortimer PGS; Armenia J; Lukashchuk N; Shah N; Dean E; Park WY; Lee J
Ann Oncol; 2022 Feb; 33(2):193-203. PubMed ID: 34710570
[TBL] [Abstract] [Full Text] [Related]
16. Kinase Inhibitors of DNA-PK, ATM and atr in Combination with Ionizing Radiation Can Increase Tumor Cell Death in HNSCC Cells While Sparing Normal Tissue Cells.
Faulhaber EM; Jost T; Symank J; Scheper J; Bürkel F; Fietkau R; Hecht M; Distel LV
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34204447
[TBL] [Abstract] [Full Text] [Related]
17. Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair Agent, in Combination with Weekly Paclitaxel in Refractory cancer.
Kim ST; Smith SA; Mortimer P; Loembé AB; Cho H; Kim KM; Smith C; Willis S; Irurzun-Arana I; Berges A; Hong JY; Park SH; Park JO; Park YS; Lim HY; Kang WK; Kozarewa I; Pierce AJ; Dean E; Lee J
Clin Cancer Res; 2021 Sep; 27(17):4700-4709. PubMed ID: 33975862
[TBL] [Abstract] [Full Text] [Related]
18. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial.
Eggermont AMM; Blank CU; Mandalà M; Long GV; Atkinson VG; Dalle S; Haydon AM; Meshcheryakov A; Khattak A; Carlino MS; Sandhu S; Larkin J; Puig S; Ascierto PA; Rutkowski P; Schadendorf D; Koornstra R; Hernandez-Aya L; Di Giacomo AM; van den Eertwegh AJM; Grob JJ; Gutzmer R; Jamal R; Lorigan PC; van Akkooi ACJ; Krepler C; Ibrahim N; Marreaud S; Kicinski M; Suciu S; Robert C;
Lancet Oncol; 2021 May; 22(5):643-654. PubMed ID: 33857412
[TBL] [Abstract] [Full Text] [Related]
19. Prevalence of Homologous Recombination Pathway Gene Mutations in Melanoma: Rationale for a New Targeted Therapeutic Approach.
Kim KB; Soroceanu L; de Semir D; Millis SZ; Ross J; Vosoughi E; Dar AA; Nosrati M; Desprez PY; Ice R; Chen M; Chetal K; Bhattacharjee A; Moretto J; Leong SP; Singer MI; Parrett BM; Minor DR; McAllister S; Miller JR; Salomonis N; Kashani-Sabet M
J Invest Dermatol; 2021 Aug; 141(8):2028-2036.e2. PubMed ID: 33610559
[TBL] [Abstract] [Full Text] [Related]
20. Reposition of the Fungicide Ciclopirox for cancer treatment.
Huang Z; Huang S
Recent Pat Anticancer Drug Discov; 2021; 16(2):122-135. PubMed ID: 33573561
[TBL] [Abstract] [Full Text] [Related]
[Next]
